Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Grows By 78.6%

AngioDynamics, Inc. (NASDAQ:ANGO) was the recipient of a large growth in short interest in January. As of January 31st, there was short interest totalling 1,470,000 shares, a growth of 78.6% from the January 15th total of 822,900 shares. Based on an average trading volume of 677,900 shares, the days-to-cover ratio is presently 2.2 days.

Insider Buying and Selling

In other AngioDynamics news, SVP Warren Nighan, Jr. sold 4,060 shares of AngioDynamics stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $12.31, for a total value of $49,978.60. Following the transaction, the senior vice president now directly owns 41,817 shares in the company, valued at approximately $514,767.27. The trade was a 8.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 5.40% of the stock is owned by company insiders.

Institutional Trading of AngioDynamics

Hedge funds and other institutional investors have recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new stake in shares of AngioDynamics in the fourth quarter valued at about $28,000. R Squared Ltd purchased a new stake in shares of AngioDynamics in the fourth quarter valued at about $49,000. US Bancorp DE boosted its holdings in shares of AngioDynamics by 1,938.0% in the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 6,376 shares in the last quarter. Quarry LP boosted its holdings in shares of AngioDynamics by 40.9% in the third quarter. Quarry LP now owns 8,518 shares of the medical instruments supplier’s stock valued at $66,000 after acquiring an additional 2,471 shares in the last quarter. Finally, CWM LLC boosted its holdings in shares of AngioDynamics by 981.3% in the third quarter. CWM LLC now owns 9,732 shares of the medical instruments supplier’s stock valued at $76,000 after acquiring an additional 8,832 shares in the last quarter. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Stock Performance

NASDAQ ANGO opened at $10.45 on Thursday. AngioDynamics has a one year low of $5.26 and a one year high of $13.50. The firm’s fifty day moving average is $10.36 and its two-hundred day moving average is $8.29.

AngioDynamics (NASDAQ:ANGO) last issued its earnings results on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07. The business had revenue of $72.90 million for the quarter, compared to the consensus estimate of $70.93 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. As a group, research analysts expect that AngioDynamics will post -0.37 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright lifted their price objective on shares of AngioDynamics from $14.00 to $15.00 and gave the company a “buy” rating in a research note on Friday, January 10th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.